These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19463071)

  • 1. Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions.
    Coremans G; Snoeck R
    Expert Opin Pharmacother; 2009 Jun; 10(8):1343-52. PubMed ID: 19463071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cidofovir in the treatment of HPV-associated lesions.
    Snoeck R; Andrei G; De Clercq E
    Verh K Acad Geneeskd Belg; 2001; 63(2):93-120, discussion 120-2. PubMed ID: 11436421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
    Snoeck R; Bossens M; Parent D; Delaere B; Degreef H; Van Ranst M; Noël JC; Wulfsohn MS; Rooney JF; Jaffe HS; De Clercq E
    Clin Infect Dis; 2001 Sep; 33(5):597-602. PubMed ID: 11477525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local treatment of HPV-induced skin lesions by Cidofovir.
    Stragier I; Snoeck R; De Clercq E; Van Den Oord JJ; Van Ranst M; De Greef H
    J Med Virol; 2002 Jun; 67(2):241-5. PubMed ID: 11992585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
    Lamoth F; Pascual M; Erard V; Venetz JP; Nseir G; Meylan P
    Antivir Ther; 2008; 13(8):1001-9. PubMed ID: 19195325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
    Snoeck R; Noel JC; Muller C; De Clercq E; Bossens M
    J Med Virol; 2000 Feb; 60(2):205-9. PubMed ID: 10596022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
    Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
    Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.
    Cha S; Johnston L; Natkunam Y; Brown J
    Transpl Infect Dis; 2005; 7(3-4):158-61. PubMed ID: 16390407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
    Andrei G; Topalis D; De Schutter T; Snoeck R
    Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study.
    Cesaro S; Hirsch HH; Faraci M; Owoc-Lempach J; Beltrame A; Tendas A; Baltadakis I; Dalle JH; Koc Y; Toporski J; Styczynski J; Yesilipek MA; Heinz W; Caniglia M; Rascon J; Fauser AA; Michallet M; Lopez-Corral L; Neuburger S; Tridello G; Einsele H;
    Clin Infect Dis; 2009 Jul; 49(2):233-40. PubMed ID: 19522651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
    De Clercq E
    Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis.
    Major T; Sziklai I; Czeglédy J; Gáll T; Gergely L; Szarka K
    Anticancer Res; 2008; 28(4B):2169-74. PubMed ID: 18751391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of topical and intralesional cidofovir.
    Zabawski EJ
    Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata.
    Coremans G; Margaritis V; Snoeck R; Wyndaele J; De Clercq E; Geboes K
    Dis Colon Rectum; 2003 Aug; 46(8):1103-8; discussion 1108-9. PubMed ID: 12907906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    Donne AJ; Rothera MP; Homer JJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
    Dancey DR; Chamberlain DW; Krajden M; Palefsky J; Alberti PW; Downey GP
    Chest; 2000 Oct; 118(4):1210-4. PubMed ID: 11035700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
    Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
    Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.